olfactory receptor family 2 subfamily Q member 1 pseudogeneGenealiases: []
Q-omics provides the consensus-scored OR2Q1P profile across patient tissues and cancer cell-line models. OR2Q1P expression is associated with patient survival in 8 of 34 cancer types, with the highest sampling consensus in THCA. Among the 18 cancer types available for tumor–normal comparison, OR2Q1P is differentially expressed in 1, with the highest sampling consensus in KIRC. Additionally, OR2Q1P RNA expression shows 6,059 significant pathway-activity associations, with the highest sampling consensus in STAD. Together, these results highlight THCA, KIRC, and STAD as cancer lineages where OR2Q1P shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.
Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.
Premium analyses for OR2Q1P — synthetic lethality, tumor antigen, and pembrolizumab response.
This table summarizes OR2Q1P survival associations across molecular data types. OR2Q1P RNA expression shows survival associations in the most cancer types (8). The rightmost column indicates the cancer type with the highest sampling consensus for each molecular layer.
This table ranks reproducible OR2Q1P RNA expression–survival associations across cancer types. High OR2Q1P expression shows unfavorable associations in THCA, BLCA, LGG, SKCM, KIRP and UVM. The THCA Kaplan–Meier curve shows clear separation, with the high-expression group declining faster, consistent with the unfavorable association (log-rank p < 0.001). Together, the overview and detailed table identify THCA as the clearest survival context for OR2Q1P RNA expression.
This table summarizes OR2Q1P tumor–normal expression differences by data type. RNA shows broader differences across cancer types, with a lineage consensus of 1. The strongest signals are observed in KIRC for RNA.
This table ranks reproducible tumor–normal expression differences for OR2Q1P. A negative fold-change indicates higher expression in normal tissue than in tumor tissue. OR2Q1P shows lower tumor expression in KIRC. The KIRC box plot shows higher OR2Q1P RNA expression in normal versus tumor tissue (log2 FC = −0.008, t-test p = .027).
This table shows molecular features associated with OR2Q1P in patient tissues and cancer cell lines. In patient samples, OR2Q1P shows the broadest associations at the RNA and protein expression levels, with STAD recurring as the lineage with the largest associated feature set.
